Floxacin 10%
For the treatment of infections of the alimentary, respiratory and urinary tract, enzootic pneumonia, atrophic rhinitis, septicaemia, MMA syndrome and other bacterial infections caused by organisms sensitive to enrofloxacin in cattle, sheep, goats, pigs, rabbits, dogs, cats.
Enrofloxacin is a synthetic chemotherapeutic agent from the group of the fluoroquinolones. It inhibits the activity of DNA gyrase and blocks DNA replication and protein synthesis of pathogenic bacteria providing bactericidal effect. Enrofloxacin has antimicrobial activity against Gram-negative (Escherichia coli, Klebsiella spp., Salmonella spp., Proteus spp., Campylobacter spp., Pseudomonas aeruginosa, Bordetella spp., Pasteurella spp., Haemophilus spp., Actinobacillus spp., Brucella spp.) and Gram-positive bacteria (Staphylococcus epidermidis, Staphylococcus aureus, including beta-lactamase-producing strains), mycoplasma, ureaplasma and chlamydia. Enrofloxacin has moderate activity against some Gram-positive aerobic bacteria (Streptococcus pyogenes, Streptococcus pneumoniae). Gram-positive anaerobic bacteria including Clostridium spp., protozoa, fungi and viruses are not susceptible to the enrofloxacin. Prolonged use of the enrofloxacin does not develop resistance in bacteria.
Active ingredient |
Enrofloxacin ……………………………..…..100 mg. |
Dosage and administration |
For intramuscular injection in pigs at the ear base once daily. For subcutaneous injection to all other target animals once daily.
|
Withdrawal period |
Milk: 10 days.
Meat: 15 days.
|
Package |
Glass vials of 100 ml. |
Shelf life |
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
|
Storage conditions |
Store in the original package between 5°C to 25°C, protected from light and moisture. |